Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroids for benign vocal fold lesions
NCT02286960Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Jul 2013
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of prednisone in Benign vocal fold lesion (BVFL) (2 arms), sponsored by NYU Langone Health. Primary endpoint: Consensus Auditory-Perceptual Evaluation of Voice at 2 months. Started Jul 2013; status: completed.
02
Drugs
prednisone
03
Conditions
Benign vocal fold lesion (BVFL)
Beyond the preview
Go deeper on NCT02286960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02286960.